GlassScriptPhysician profile
Vershalee Shukla
NPI 1366726788
$19,186.16
in general payments reported to CMS, 2019-2025
37 companies · $13K in 2025
The $13K reported for 2025 was more than what 97% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $240 · 2021: $2,675 · 2022: $350 · 2023: $492 · 2024: $1,242 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,975 · Travel and Lodging: $3,366 · Food and Beverage: $1,737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,975.00 |
| Travel and Lodging | $3,366.48 |
| Food and Beverage | $1,736.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $12,056.92 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $2,391.11 | 2021-2024 | Imfinzi |
| Angiodynamics, INC. | $889.96 | 2025 | Nanoknife |
| Histosonics, INC. | $672.39 | 2024 | |
| Varian Medical Systems, INC. | $589.44 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $388.54 | 2021-2024 | Halcyon, Truebeam |
| Progenics Pharmaceuticals, INC. | $233.69 | 2023-2025 | Pylarify |
| Myriad Genetic Laboratories, INC. | $201.97 | 2020-2023 | Prolaris |
| Blue Earth Diagnostics | $180.41 | 2021-2025 | Posluma |
| Menarini Silicon Biosystems, INC. | $151.58 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $140.25 | 2019-2022 | |
| Galvanize Therapeutics, INC | $133.77 | 2025 | Aliya System |
| Novartis Pharmaceuticals Corporation | $129.49 | 2024-2025 | |
| Tempus Ai, INC | $110.73 | 2024-2025 | Xt Cdx |
| Janssen Biotech, INC. | $107.53 | 2019-2024 | Erleada |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $103.92 | 2019-2022 | |
| Accuray Incorporated | $87.00 | 2019-2022 | |
| Genzyme Corporation | $64.15 | 2020-2021 | |
| Zap Surgical Systems, INC. | $62.39 | 2019 | |
| Qt Imaging, INC. | $48.83 | 2019 | |
| Philips North America LLC | $47.44 | 2025 | Spectral Ct 7500 Rt |
| Gt Medical Technologies, INC | $46.18 | 2023 | Gammatile |
| Adaptive Biotechnologies Corporation | $35.01 | 2023 | Clonoseq |
| Lucid Diagnostics INC. | $32.13 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $32.13 | 2024 | Keytruda |
| Icotec Medical INC. | $29.39 | 2022 | |
| Novocure INC. | $28.19 | 2025 | Optune Lua (Novottf-200t) |
| Sun Pharmaceutical Industries INC. | $26.73 | 2020 | |
| Abbvie INC. | $24.19 | 2023 | Lupron Depot |
| Eisai INC. | $23.52 | 2024 | |
| Pfizer INC. | $21.47 | 2023 | |
| Dendreon Pharmaceuticals LLC | $20.24 | 2019 | |
| Elekta, INC. | $18.36 | 2023 | Elekta Medical Linear Accelerator |
| Reflexion Medical, INC. | $17.40 | 2023 | Reflexion Medical Radiotherapy System |
| Bayer Healthcare Pharmaceuticals INC. | $15.78 | 2024 | |
| Foundation Medicine, INC. | $12.32 | 2020 | |
| Profound Medical Corp. | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vershalee Shukla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.